Pulse Biosciences Inc (FRA:6L8)
€ 16.5 -0.2 (-1.2%) Market Cap: 1.13 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 13.98 GF Score: 40/100

Q4 2022 Pulse Biosciences Inc Earnings Call Transcript

Mar 30, 2023 / 08:30PM GMT
Release Date Price: €2.12 (-7.69%)
Operator

Ladies and gentlemen, greetings, and welcome to the Pulse Biosciences Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host Trip Taylor, Investor Relations. Please go ahead.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, March 30, 2023, only and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations and other information. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued earlier today and in our filings with the Securities and Exchange Commission. Our SEC filings can be found on our website or on the SEC's website. Investors are cautioned not to place undue reliance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot